Affiliated with a Castle Connolly Top Hospital
Who is Dr. Dahl, Pediatric Hematologist-Oncologist in Palo Alto, CA?
Dr. Gary Dahl, MD is a Pediatric Hematologist-Oncologist, who primarily practices in Palo Alto, CA. He is board certified. Dr. Dahl graduated from Oregon Health & Science University School of Medicine and completed his residency at Or Hlth Sci Univ Hosp, Pediatrics; Or Hlth Sci Univ Hosp, Flexible Or Transitional Year. Dr. Dahl is fluent in English and Spanish, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Dahl’s office at (650) 497-8000.
What are Areas of Expertise for Dr. Dahl?
Dr. Gary Dahl, MD is a highly-rated, board-certified Pediatric Hematologist-Oncologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Dahl empowers patients to confidently navigate their health journey, specializing in Brain Tumors, Leukemia, Stem Cell Transplant, and comprehensive wellness support. Serving the Palo Alto, CA community, Dr. Dahl is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Dahl go to medical school and complete their residency?
Residency: Or Hlth Sci Univ Hosp, Pediatrics; Or Hlth Sci Univ Hosp, Flexible Or Transitional Year | Oregon Health & Science University Program
Medical School: Or Hlth Sci Univ Sch of Med, Portland Or | Oregon Health And Science University School of Medicine,Portland, Or, United States | Oregon Health & Science University School of Medicine
Is Dr. Dahl board certified as a Pediatric Hematologist-Oncologist?
Yes, Dr. Gary Dahl, MD is board certified by the American Board of Pediatrics
What languages does Dr. Dahl speak?
Dr. Dahl and their clinical team can communicate with patients in the following languages:
English
Spanish
What conditions does a Pediatric Hematologist-Oncologist like Dr. Dahl typically treat?
As a Pediatric Hematologist-Oncologist, Dr. Dahl diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Dahl. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Acute Lymphocytic Leukemia in Remission
- Acute Lymphocytic Leukemia
- ALL Leukemia in Remission
- Acute Lymphoblastic Leukemia in Remission
- Childhood Leukemia in Remission
ICD-10 Codes:
- C9101: Acute lymphoblastic leukemia, in remission
What procedures does a Pediatric Hematologist-Oncologist like Dr. Dahl typically perform?
As a Pediatric Hematologist-Oncologist, procedures performed by Dr. Gary Dahl may include:
- 3D Conformal Radiotherapy
- Adaptive Radiation Therapy (ART)
- Adrenalectomy
- Blood Thinning Therapy / Anticoagulation
- Blood Transfusion Consultation
- Blood Transfusion Follow Up
- Bone Excision
- Bone Grafting
Please contact Dr. Dahl's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Dahl accept my insurance?
Dr. Dahl accepts most major insurance plans. Important: Please call our office at (650) 497-8000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Dahl accept in Palo Alto, CA?
Dr. Dahl in Palo Alto, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
California Water Service Group
View All Insurances
Where is Dr. Dahl's office located?
Recognitions
Publications
Development and validation of a single-cell network profiling assay
, 2013
Pediatric Acute Myeloid Leukemia as Classified Using 2008 WHO Criteria: A Single-Center Experience.
, 2013
Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome
, 2013
Treatment Outcome in Older Patients With Childhood Acute Myeloid Leukemia
, 2012
Effect of body mass index on the outcome of children with acute myeloid leukemia
, 2012
Massive evolution of the immunoglobulin heavy chain locus
, 2012
Concurrent cyclophosphamide
, 2012
HLA-DP genetic variation
, 2012
Comparative Alysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia
, 2012
Variation in xenobiotic transport and metabolism genes, household chemical exposures
, 2012
Phase II study of 2-chlorodeoxyadenosine plus idarubicin for children with acute myeloid leukaemia
, 2012
Therapeutic Complications in a Patient With High-Risk Acute Lymphoblastic Leukemia
, 2012
Langerhans cell histiocytosis in a 5-month-old presenting with biparietal masses Case report
, 2010
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia
, 2010
Concurrent Treatment of Steroid-Related Mood and Psychotic Symptoms With Risperidone
, 2010
Phase I Study of Valspodar
, 2010
WT1 Expression at Diagnosis Does Not Predict Survival in Pediatric AML
, 2009
Molecular inversion probes reveal patterns of 9p21 deletion
, 2009
Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia
, 2008
Tissue microarrays from bone marrow aspirates for high
, 2008
Comparison of antitumor effects of multitargeted tyrosine kise inhibitors
, 2008
Identification of a novel p53 in-frame deletion in a Li-Fraumeni-like family
, 2008
Cardiomyopathy in children with down syndrome treated for acute myeloid leukemia
, 2008
Concerns about infertility risks among pediatric oncology patients and their parents
, 2008
Outcomes of transplantation in children with primary hepatic maligncy
, 2007
Reinduction of relapsed acute promyelocytic leukemia with ATRA
, 2007
A syndrome of irreversible leukoencephalopathy following pediatric allogeneic bone marrow
, 2007
Attitudes and practices of pediatric oncology providers regarding fertility issues
, 2007
CpG island methylator phenotype and childhood leukemia
, 2006
A prospective study of the tural history of transient leukemia (TL)
, 2006
Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is
, 2006
Anthracyclines cause endothelial injury in pediatric cancer patients: A pilot study
, 2006
Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission
, 2006
Profile of daily life in children with brain tumors
, 2005
Gene expression profiles at diagnosis
, 2004
Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis
, 2004
Critical windows of exposure to household pesticides and risk of childhood leukemia
, 2002
Pharmacokinetic interactions of cyclosporine with etoposide
, 2002
Surveillance neuroimaging to detect relapse in childhood brain tumors
, 2001
Modified cyclophosphamide, hydroxydaunorubicin
, 2001
Weekly dosing of carboplatin increases risk of allergy in children
, 2001
Magement of children with metastatic spil myxopapillary ependymoma using craniospil irradiation
, 2000
Mitoxantrone, etoposide
, 2000
A multi-institutiol retrospective study of intracranial ependymoma in children
, 1999
Bcl-2 expression does not correlate with patient outcome in pediatric acute myelogenous leukemia
, 1998
Neoplastic disorders after pediatric heart transplantation.
, 1993
What is Dr. Dahl's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Dahl's National Provider Identifier (NPI) number is 1164595856.
What common questions do patients ask about Dr. Dahl?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Dahl
What is Dr. Gary Dahl's specialty?
Dr. Dahl is a Pediatric Hematologist-Oncologist near Palo Alto, CA.
What does a Pediatric Hematologist-Oncologist do?
A pediatrician trained in the integration of pediatrics, hematology, and oncology, specializing in the recognition and management of blood disorders and cancer in children. This expert provides comprehensive care for conditions such as anemia, bleeding disorders, and various pediatric cancers.
Is this Dr. Gary Dahl affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Dahl is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see a Pediatric Hematologist-Oncologist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see a Pediatric Hematologist-Oncologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Gary Dahl accepting new patients in Palo Alto, CA?
Yes, Dr. Gary Dahl is accepting new patients at this time.
Does Dr. Gary Dahl offer online booking?
Please contact Dr. Dahl's office at (650) 497-8000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Gary Dahl?
Please contact Dr. Dahl's office at (650) 497-8000 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Gary Dahl have?
Dr. Gary Dahl is certified by the American Board of Pediatrics.
Other Pediatric Hematologist-Oncologist Near Palo Alto, CA
Pediatric Hematologist-Oncologist
Accepting patients
Pediatric Hematologist-Oncologist
Accepting patientsPediatric Hematologist-Oncologist
Accepting patients